Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Feb;51(2):177–181. doi: 10.1136/ard.51.2.177

Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.

D M van der Heijde 1, M A van't Hof 1, P L van Riel 1, M A van Leeuwen 1, M H van Rijswijk 1, L B van de Putte 1
PMCID: PMC1005654  PMID: 1550400

Abstract

There is no agreement as to which variable best mirrors disease activity in rheumatoid arthritis (RA) and no studies have been performed on the validity of disease activity variables. In this study the validity of 10 commonly used single variables and three composite indices was tested. All patients participated in a large follow up study in two clinics. The patients (n = 233) had classical or definite RA and a disease duration of less than one year at entry. The mean follow up time was 30 months; the follow up frequency was once every four weeks; 6011 records were used in the analysis. The validation criteria included correlations with the other variables (correlational validity), with the physical disability (criterion validity I), and with the radiographically determined damage of hands and feet (construct validity). The judgment of a group of rheumatologists in clinical practice was also used as a model of criterion validity (II). In this comparison the disease activity score and Mallya index showed the best validity. The best single variable was the number of swollen joints. The validity of most single variables was poor and these variables were not suitable as single endpoint measures in clinical trials.

Full text

PDF
180

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bombardier C., Tugwell P., Sinclair A., Dok C., Anderson G., Buchanan W. W. Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol. 1982 Sep-Oct;9(5):798–801. [PubMed] [Google Scholar]
  2. Bull B. S., Levy W. C., Westengard J. C., Farr M., Smith P. F., Apperley J. F., Bacon P. A., Stuart J. Ranking of laboratory tests by consensus analysis. Lancet. 1986 Aug 16;2(8503):377–380. doi: 10.1016/s0140-6736(86)90063-2. [DOI] [PubMed] [Google Scholar]
  3. Bull B. S., Westengard J. C., Farr M., Bacon P. A., Meyer P. J., Stuart J. Efficacy of tests used to monitor rheumatoid arthritis. Lancet. 1989 Oct 21;2(8669):965–967. doi: 10.1016/s0140-6736(89)90965-3. [DOI] [PubMed] [Google Scholar]
  4. Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980 Feb;23(2):137–145. doi: 10.1002/art.1780230202. [DOI] [PubMed] [Google Scholar]
  5. Fries J. F. Toward an understanding of patient outcome measurement. Arthritis Rheum. 1983 Jun;26(6):697–704. doi: 10.1002/art.1780260601. [DOI] [PubMed] [Google Scholar]
  6. Ingeman-Nielsen M., Halskov O., Hansen T. M., Halberg P., Stage P., Lorenzen I. Clinical synovitis and radiological lesions in rheumatoid arthritis. A prospective study of 25 patients during treatment with remission-inducing drugs. Scand J Rheumatol. 1983;12(3):237–240. doi: 10.3109/03009748309098540. [DOI] [PubMed] [Google Scholar]
  7. Kirwan J. R., Chaput de Saintonge D. M., Joyce C. R., Currey H. L. Clinical judgment in rheumatoid arthritis. I. Rheumatologists' opinions and the development of 'paper patients'. Ann Rheum Dis. 1983 Dec;42(6):644–647. doi: 10.1136/ard.42.6.644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kirwan J. R., Chaput de Saintonge D. M., Joyce C. R., Holmes J., Currey H. L. Inability of rheumatologists to describe their true policies for assessing rheumatoid arthritis. Ann Rheum Dis. 1986 Feb;45(2):156–161. doi: 10.1136/ard.45.2.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mallya R. K., Mace B. E. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. Rheumatol Rehabil. 1981 Feb 1;20(1):14–17. doi: 10.1093/rheumatology/20.1.14. [DOI] [PubMed] [Google Scholar]
  10. March R. E., Kirwan J. R., Reeback J. S., Holborow E. J. IgM, IgG and IgA rheumatoid factors (antiglobulins) in early rheumatoid arthritis and their production of articular index over one year. Scand J Rheumatol. 1987;16(6):407–411. doi: 10.3109/03009748709165411. [DOI] [PubMed] [Google Scholar]
  11. Meenan R. F., Gertman P. M., Mason J. H., Dunaif R. The arthritis impact measurement scales. Further investigations of a health status measure. Arthritis Rheum. 1982 Sep;25(9):1048–1053. doi: 10.1002/art.1780250903. [DOI] [PubMed] [Google Scholar]
  12. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  13. Scott D. L., Spector T. D., Pullar T., McConkey B. What should we hope to achieve when treating rheumatoid arthritis? Ann Rheum Dis. 1989 Mar;48(3):256–261. doi: 10.1136/ard.48.3.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sharp J. T., Bluhm G. B., Brook A., Brower A. C., Corbett M., Decker J. L., Genant H. K., Gofton J. P., Goodman N., Larsen A. Reproducibility of multiple-observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis. Arthritis Rheum. 1985 Jan;28(1):16–24. doi: 10.1002/art.1780280104. [DOI] [PubMed] [Google Scholar]
  15. Sharp J. T., Lidsky M. D., Duffy J. Clinical responses during gold therapy for rheumatoid arthritis. Changes in synovitis, radiologically detectable erosive lesions, serum proteins, and serologic abnormalities. Arthritis Rheum. 1982 May;25(5):540–549. doi: 10.1002/art.1780250508. [DOI] [PubMed] [Google Scholar]
  16. Sharp J. T. Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum. 1989 Feb;32(2):221–229. doi: 10.1002/anr.1780320218. [DOI] [PubMed] [Google Scholar]
  17. Sharp J. T., Young D. Y., Bluhm G. B., Brook A., Brower A. C., Corbett M., Decker J. L., Genant H. K., Gofton J. P., Goodman N. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum. 1985 Dec;28(12):1326–1335. doi: 10.1002/art.1780281203. [DOI] [PubMed] [Google Scholar]
  18. Thompson P. W., Silman A. J., Kirwan J. R., Currey H. L. Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response. Arthritis Rheum. 1987 Jun;30(6):618–623. doi: 10.1002/art.1780300603. [DOI] [PubMed] [Google Scholar]
  19. Tugwell P., Bombardier C. A methodologic framework for developing and selecting endpoints in clinical trials. J Rheumatol. 1982 Sep-Oct;9(5):758–762. [PubMed] [Google Scholar]
  20. van Riel P. L., van de Putte L. B., Gribnau F. W., Macrae K. D. Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study. Clin Rheumatol. 1984 Mar;3 (Suppl 1):51–56. doi: 10.1007/BF03342622. [DOI] [PubMed] [Google Scholar]
  21. van der Heijde D. M., van 't Hof M. A., van Riel P. L., Theunisse L. A., Lubberts E. W., van Leeuwen M. A., van Rijswijk M. H., van de Putte L. B. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990 Nov;49(11):916–920. doi: 10.1136/ard.49.11.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. van der Heijde D. M., van Riel P. L., Nuver-Zwart I. H., Gribnau F. W., vad de Putte L. B. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989 May 13;1(8646):1036–1038. doi: 10.1016/s0140-6736(89)92442-2. [DOI] [PubMed] [Google Scholar]
  23. van der Heijde D. M., van Riel P. L., van de Putte L. B. Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine. Scand J Rheumatol. 1990;19(6):407–412. doi: 10.3109/03009749009097629. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES